Market Update: Johnson & Johnson (NYSE:JNJ) – Johnson & Johnson Announces Patent and Trademark Office Action Related to REMICADE®

[PR Newswire] – The reader is cautioned not to rely on these forward-looking statements. If underlying assumptions prove inaccurate or known or unknown risks or uncertainties materialize, actual results could vary materially from . . . → Read More: Market Update: Johnson & Johnson (NYSE:JNJ) – Johnson & Johnson Announces Patent and Trademark Office Action Related to REMICADE® Similar Articles: Market Update: Johnson & Johnson (NYSE:JNJ) – Johnson & Johnson Announces Quarterly Dividend for First Quarter 2015 Stock Update: Johnson & Johnson (NYSE:JNJ) – Johnson & Johnson Reports 2014 Third-Quarter Results: Stock Update (NYSE:JNJ): FDA says Johnson & Johnson recalls some jaw implants